Search Page

1

Cite

Share

Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship?

Derdemezis CS, Voulgari PV, Drosos AA, Kiortsis DN. Derdemezis CS, et al. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):712-27. Epub 2011 Sep 1. Clin Exp Rheumatol. 2011. PMID: 21640051 Review.

Cite

Share

2

Cite

Share

Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study.

Derdemezis C, Filippatos T, Tselepis A, Mikhailidis D, Elisaf M. Derdemezis C, et al. Expert Opin Pharmacother. 2008 Aug;9(11):1829-37. doi: 10.1517/14656566.9.11.1829. Expert Opin Pharmacother. 2008. PMID: 18627322 Clinical Trial.

Cite

Share

3

Cite

Share

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.

Filippatos TD, Tsimihodimos V, Derdemezis CS, Gazi IF, Saougos V, Mikhailidis DP, Tselepis AD, Elisaf MS. Filippatos TD, et al. Among authors: derdemezis cs. Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):330-6. doi: 10.1016/j.numecd.2011.07.002. Epub 2011 Oct 2. Nutr Metab Cardiovasc Dis. 2013. PMID: 21963513

Cite

Share

4

Cite

Share

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.

Filippatos TD, Derdemezis CS, Voulgari PV, Tsimihodimos V, Elisaf MS, Tselepis AD, Drosos AA. Filippatos TD, et al. Among authors: derdemezis cs. Scand J Rheumatol. 2013;42(3):169-75. doi: 10.3109/03009742.2012.745013. Epub 2013 Jan 14. Scand J Rheumatol. 2013. PMID: 23311768

Cite

Share

5

Cite

Share

Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment.

Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN. Derdemezis CS, et al. Clin Exp Rheumatol. 2010 Nov-Dec;28(6):880-3. Epub 2011 Jan 3. Clin Exp Rheumatol. 2010. PMID: 21122270 Clinical Trial.

Cite

Share

6

Cite

Share

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

Filippatos TD, Derdemezis CS, Kiortsis DN, Tselepis AD, Elisaf MS. Filippatos TD, et al. Among authors: derdemezis cs. J Endocrinol Invest. 2007 Apr;30(4):323-6. doi: 10.1007/BF03346300. J Endocrinol Invest. 2007. PMID: 17556870

Cite

Share

7

Cite

Share

Combination of fenofibrate with non-statin drug regimens.

Agouridis AP, Filippatos TD, Derdemezis CS, Mikhailidis DP, Elisaf MS. Agouridis AP, et al. Among authors: derdemezis cs. Curr Pharm Des. 2010 Oct;16(30):3401-16. doi: 10.2174/138161210793563464. Curr Pharm Des. 2010. PMID: 20819059 Review.

Cite

Share

8

Cite

Share

Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

Milionis HJ, Filippatos TD, Derdemezis CS, Kalantzi KJ, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Milionis HJ, et al. Among authors: derdemezis cs. Eur J Neurol. 2007 Jul;14(7):762-9. doi: 10.1111/j.1468-1331.2007.01849.x. Eur J Neurol. 2007. PMID: 17594332

Cite

Share

9

Cite

Share

Increased plasma visfatin levels in subjects with the metabolic syndrome.

Filippatos TD, Derdemezis CS, Gazi IF, Lagos K, Kiortsis DN, Tselepis AD, Elisaf MS. Filippatos TD, et al. Among authors: derdemezis cs. Eur J Clin Invest. 2008 Jan;38(1):71-2. doi: 10.1111/j.1365-2362.2007.01904.x. Eur J Clin Invest. 2008. PMID: 18173555 No abstract available.

Cite

Share

10

Cite

Share

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia.

Nakou ES, Filippatos TD, Kiortsis DN, Derdemezis CS, Tselepis AD, Mikhailidis DP, Elisaf MS. Nakou ES, et al. Among authors: derdemezis cs. Expert Opin Pharmacother. 2008 Dec;9(18):3151-8. doi: 10.1517/14656560802548430. Expert Opin Pharmacother. 2008. PMID: 19040336 Clinical Trial.

Cite

Share